Company Overview
A multi-variate, multi-channel healthcare data platform. Its flagship solution, âVersus,â leverages artificial intelligence and machine learning to analyze data collected from retail pharmacies. The platform provides pharmaceutical companies with critical insights into product performance, market share, and competitor activity, enabling more informed decision-making and efficient resource allocation.
Company History
PBR Life Sciences was founded in 2015. Public founder information in the source set points to Ayodeji Alaran. Its latest captured funding/news event in the source set was in 2024, recorded as Pre-Seed.
Key Facts
| Country | Nigeria |
| Founded | 2015 |
| Founders | Ayodeji Alaran |
| Sector | Healthcare |
| Operational Status | Appears active |
| Latest Round | Pre-Seed, 2024, $1M |
| Total Disclosed Funding | $1.12M |
| Website | https://pbrinsight.com/ |
Business Model
PBR Life Sciences appears to operate a product-led business model in the Healthcare sector. Based on public descriptions, it generates value through technology-enabled services, software, marketplace access, operations, or financial infrastructure.
Products and Services
- Pharmaceutical or care infrastructure
- Hospital or provider digitisation
- Supply-chain services
- Patient access tools
Funding and Market Position
Public deal records in the source set show 2 disclosed funding event(s), with about $1.12M captured in total. The most recent event is recorded as Pre-Seed, 2024, $1M.
Contact Information
The most reliable public contact channel in the source set is the official website: https://pbrinsight.com/. Public phone numbers and public support emails were not consistently available at scale, so the website/contact form is the best public route.
Company Location
Operational Status
Latest public funding/news source in 2024 suggests the startup was operating at that time. Status recorded here is a best-effort assessment as of March 21, 2026.
Why This Startup Matters
As a Nigerian startup in the Healthcare space, PBR Life Sciences matters because it addresses local market problems with a scalable digital product or operational model.
Sources
Related Startups
- RxAll
- Platos Health
- Myltura

